Amazon.com Inc (AMZN)vsMEDIFAST INC (MED)
AMZN
Amazon.com Inc
$256.78
+1.94%
CONSUMER CYCLICAL · Cap: $2.77T
MED
MEDIFAST INC
$12.04
-0.08%
CONSUMER CYCLICAL · Cap: $141.66M
Smart Verdict
WallStSmart Research — data-driven comparison
Amazon.com Inc generates 244646% more annual revenue ($775.68B vs $316.93M). AMZN leads profitability with a 17.4% profit margin vs -8.1%. MED appears more attractively valued with a PEG of 0.97. AMZN earns a higher WallStSmart Score of 72/100 (B).
AMZN
Strong Buy72
out of 100
Grade: B
MED
Hold45
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-59.1%
Fair Value
$161.40
Current Price
$256.78
$95.38 premium
Intrinsic value data unavailable for MED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Earnings expanding 242.3% YoY
Every $100 of equity generates 25 in profit
19.6% revenue growth
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Growing faster than its price suggests
Areas to Watch
Weak financial health signals
Negative free cash flow — burning cash
Smaller company, higher risk/reward
Weak financial health signals
ROE of -10.1% — below average capital efficiency
Revenue declined 27.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : AMZN
The strongest argument for AMZN centers on Market Cap, EPS Growth, Return on Equity. Profitability is solid with margins at 17.4% and operating margin at 13.7%. Revenue growth of 19.6% demonstrates continued momentum.
Bull Case : MED
The strongest argument for MED centers on Price/Book, Altman Z-Score, Debt/Equity. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bear Case : AMZN
The primary concerns for AMZN are Piotroski F-Score, Free Cash Flow.
Bear Case : MED
The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.
Key Dynamics to Monitor
AMZN profiles as a growth stock while MED is a turnaround play — different risk/reward profiles.
AMZN carries more volatility with a beta of 1.44 — expect wider price swings.
AMZN is growing revenue faster at 19.6% — sustainability is the question.
MED generates stronger free cash flow (728,000), providing more financial flexibility.
Bottom Line
AMZN scores higher overall (72/100 vs 45/100), backed by strong 17.4% margins and 19.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Amazon.com Inc
CONSUMER CYCLICAL · INTERNET RETAIL · USA
Amazon.com, Inc. is an American multinational technology company which focuses on e-commerce, cloud computing, digital streaming, and artificial intelligence. It is one of the Big Five companies in the U.S. information technology industry, along with Google, Apple, Microsoft, and Facebook. The company has been referred to as one of the most influential economic and cultural forces in the world, as well as the world's most valuable brand.
Visit Website →MEDIFAST INC
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Visit Website →Compare with Other INTERNET RETAIL Stocks
Want to dig deeper into these stocks?